U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06916013) titled 'Focal Laser Ablation in Prostate Cancer' on Feb. 14.
Brief Summary: To assess the effectiveness of MRI-US or PSMA PET/CT-U/S fusion-guided focal laser ablation (FLA) for the treatment of a localized, intermediate-risk prostate cancer in terms of short-term oncological & functional outcomes.
Study Start Date: April 20
Study Type: OBSERVATIONAL
Condition:
Prostate Cancer
Laser
Intervention:
PROCEDURE: Focal laser ablation
Targeted focal laser ablation
PROCEDURE: Focal laser ablation
Targeted focal laser ablation of localized intermediate-risk prostate cancer
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ain Shams Universi...